Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC100506258 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ARL17B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2G6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LARGE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTP4A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAALAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF417 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506548 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM26-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC4A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DBT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DGAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on